WOBURN, Mass.--(BUSINESS WIRE)--Researchers at Nuvera Biosciences and The University of Texas M.D. Anderson Cancer Center have developed predictors of response to chemotherapy and hormonal treatments in breast cancer patients. Results of these studies will be announced at the Annual AACR Meeting in Los Angeles, CA.
